1-5 of 5
Authors: Angelo Delmonte
Save search
Sort by
Journal Article

Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial

PDF
Emilio Bria and others
The Oncologist, Volume 29, Issue 5, May 2024, Pages e690–e698, https://doi.org/10.1093/oncolo/oyad342
Published: 20 February 2024
Journal Article

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population

PDF
Lucio Crinò and others
The Oncologist, Volume 24, Issue 11, November 2019, Pages e1165–e1171, https://doi.org/10.1634/theoncologist.2018-0737
Published: 17 April 2019
Journal Article

Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets

PDF
Francesca Toffalorio and others
The Oncologist, Volume 19, Issue 4, April 2014, Pages 344–345, https://doi.org/10.1634/theoncologist.2013-0335
Published: 27 March 2014
Journal Article

Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets

PDF
Francesca Toffalorio and others
The Oncologist, Volume 19, Issue 4, April 2014, Pages 344–345, https://doi.org/10.1634/theoncologist.2013-0335
Published: 27 March 2014
Journal Article

Beyond Monoclonal Antibodies: New Therapeutic Agents in Non-Hodgkin’s Lymphomas

PDF
Angelo Delmonte and others
The Oncologist, Volume 14, Issue 5, May 2009, Pages 511–525, https://doi.org/10.1634/theoncologist.2008-0214
Published: 01 May 2009